VIR

Vir Biotechnology, Inc.

Healthcare›Biotechnology|NASDAQ Global Select|US

Price

$9.06

Market Cap

$1.45B

Beta

1.71

P/E

0.0

Div Yield

—

Sector Median P/E

22.6

Key Metrics

Revenue Growth (YoY)-7.61%

EPS Growth (YoY)+17.28%

Revenue CAGR 3Y-65.12%

P/E Ratio0.0

PEG Ratio—

FCF Yield-27.06%

Debt / Equity0.24

Interest Coverage999.0x

No credit card required

Already have an account? Sign in to view the full analysis for VIR.